BioAffinity Technologies Q4 EPS $(0.26) Up From $(0.44) YoY, Sales $2.21M Down From $2.35M YoY
BioAffinity Technologies Q4 EPS $(0.26) Up From $(0.44) YoY, Sales $2.21M Down From $2.35M YoY
BioAffinity Technologies第四季度每股收益美元（0.26美元）高于同比（0.44美元），销售额为221万美元，低于同比235万美元
bioAffinity Technologies (NASDAQ:BIAF) reported quarterly losses of $(0.26) per share. This is a 40.91 percent increase over losses of $(0.44) per share from the same period last year. The company reported $2.21 million in sales this quarter. This is a 5.67 percent decrease over sales of $2.35 million the same period last year.
BioAffinity Technologies（纳斯达克股票代码：BIAF）报告称，季度每股亏损为0.26美元。这比去年同期每股亏损0.44美元（0.44美元）增长了40.91％。该公司报告本季度销售额为221万美元。这比去年同期的235万美元销售额下降了5.67％。